Acute myeloid leukemia (AML) can be a difficult disease to cure. However, advances in AML treatment have resulted in improved remission (an absence of signs and symptoms) and cure rates.
Treatment outcomes can be broken down into four categories. The table below describes the difference between each category.
|Minimal residual disease||
|Complete molecular remission||
For survival statistics, click here.